Skip to Content


In the US, Rifabutin (rifabutin systemic) is a member of the drug class rifamycin derivatives and is used to treat Mycobacterium avium-intracellulare - Prophylaxis, Mycobacterium avium-intracellulare - Treatment, Tuberculosis - HIV Positive and Tuberculosis - Prophylaxis.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories


Antitubercular agent

Chemical Name

(9S,12E,14S,15R,16S,17R,18R,19R,20S,21S,22E,24Z)-6,16,18,20-Tetrahydroxy-1'-isobutyl-14-metoxy-7,9,15,17,19,21,25-heptametylspiro[9,4-(epoxypentadeca[1,11,13]trienoimino)-2H-furo[2',3':7,8]napht[1,2-d]imidazole-2,4'-piperidine]-5,10,26-(3H,9H)-trione 16-a (WHO)

Foreign Names

Generic Names

  • Rifabutin (OS: BAN, USAN, JAN)
  • Rifabutina (OS: DCIT)
  • Rifabutine (OS: DCF)
  • Ansamicin (IS)
  • Ansamycin (IS)
  • LM 427 (IS: FarmitaliaCarl)
  • Rifabutin (PH: BP 2016, Ph. Eur. 8, USP 38)
  • Rifabutine (PH: Ph. Eur. 8)
  • Rifabutinum (PH: Ph. Eur. 8)

Brand Names

  • Ansatipin
    Pfizer, Spain; Pfizer, Finland; Pfizer, Sweden
  • Ansatipine
    SERB Laboratoires, France
  • Macbutin
    Macleods, India
  • Mycobutin
    Pfizer, Austria; Pfizer, Australia; Pfizer, Belgium; Pfizer, Canada; Pfizer, Switzerland; Pfizer, Czech Republic; Pfizer, United Kingdom; Pfizer, Hong Kong; Pfizer, Ireland; Pfizer, Israel; Pfizer, Netherlands; Pfizer, New Zealand; Pfizer, Portugal; Pfizer, Turkey; Pfizer, Taiwan; Pfizer, South Africa; Pfizer Italia, Italy; Pfizer Japan, Japan; Pharmacia & Upjohn, United States
  • Ributin
    Lupin, India
  • Rifabutin Pfizer
    Pfizer, Denmark
  • Tambux
    Richmond, Argentina


BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.